Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Biocept, Inc. (NASDAQ: BIOC).

Full DD Report for BIOC

You must become a subscriber to view this report.


Recent News from (NASDAQ: BIOC)

Agilent Technologies and Three More Healthcare Stocks Under Our Scanner
Stock Research Monitor: CFMS, XRAY, and BIOC LONDON, UK / ACCESSWIRE / May 17, 2018/ If you want a free Stock Review on A sign up now at www.wallstequities.com/registration . On Wednesday, May 16, 2018, the NASDAQ Composite ended the trading session at 7,398.30, up 0.63%; the Dow Jo...
Source: ACCESSWIRE IA
Date: May, 17 2018 08:30
Mixed shelf filing roundup
Recent filings for mixed shelf offerings: More news on: Biocept, Inc., Tenax Therapeutics, Inc., Aemetis, Inc., Healthcare stocks news, Energy stocks news, Read more ...
Source: SeekingAlpha
Date: May, 16 2018 06:58
Biocept's (BIOC) CEO Michael Nall on Q1 2018 Results - Earnings Call Transcript
Biocept, Inc. (BIOC) Q1 2018 Results Earnings Conference Call May 15, 2018, 4:30 PM ET Executives Jody Cain - LHA Investor Relations Michael Nall - President and CEO Tim Kennedy - Senior Vice President, Operations and CFO Analysts Jason McCarthy - Maxim Group Lauren Chung...
Source: SeekingAlpha
Date: May, 15 2018 19:20
Biocept misses by $0.02, misses on revenue
Biocept (NASDAQ: BIOC ): Q1 EPS of -$0.11 misses by $0.02 . More news on: Biocept, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 15 2018 16:07
Biocept Reports First Quarter 2018 Financial Results
SAN DIEGO , May 15, 2018 /PRNewswire/ --  Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports financial results for the three mont...
Source: PR Newswire
Date: May, 15 2018 16:05
Biocept to Release First Quarter 2018 Financial Results and Host Investor Conference Call on May 15, 2018
SAN DIEGO , May 8, 2018 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing proprietary liquid biopsy tests that provide clinically actionable  information to physicians to improve cancer treatment, announces that it will ...
Source: PR Newswire
Date: May, 08 2018 08:05
Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung Cancer
SAN DIEGO , May 1, 2018 /PRNewswire/ --  Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the publication of a...
Source: PR Newswire
Date: May, 01 2018 08:05
Published Case Study Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for ALK Rearrangements
SAN DIEGO , April 27, 2018 /PRNewswire/ --  Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the publication o...
Source: PR Newswire
Date: April, 27 2018 08:05
Biocept to Webcast Presentation at the 7th Annual MicroCap Conference
SAN DIEGO , April 6, 2018 /PRNewswire/ --  Biocept, Inc . (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that President and...
Source: PR Newswire
Date: April, 06 2018 08:05
Free Post Earnings Research Report: Exact Sciences' Quarterly Revenues Jumped 148.02%
Stock Monitor: Biocept Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 6, 2018 / Active-Investors.com has just released a free earnings report on Exact Sciences Corp. (NASDAQ: EXAS ) ("EXAS"). If you want access to this report all you need to do is sign up now by clicking the...
Source: ACCESSWIRE IA
Date: April, 06 2018 07:40

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-173.213.403.802.86269,236
2018-08-163.173.243.3123.1741,200
2018-08-153.353.20993.49993.0687150,827
2018-08-144.023.6594.023.50180,666
2018-08-134.003.894.203.86103,278

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1736,98864,45857.3831Short
2018-08-1610,44526,27139.7587Short
2018-08-1516,50858,83728.0572Cover
2018-08-1441,76861,06768.3970Short
2018-08-1325,22138,21765.9942Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BIOC.


About Biocept, Inc. (NASDAQ: BIOC)

Logo for Biocept, Inc. (NASDAQ: BIOC)

Not available

 

Contact Information

     

     

    Current Share Structure

    • Market Cap: $2,644,862 - 03/20/2018
    • Issue and Outstanding: 8,396,387 - 09/29/2016

     


    Recent Filings from (NASDAQ: BIOC)

    Preliminary proxy statement providing notification matters to be brought to a vote
    Filing Type: PRE 14AFiling Source: edgar
    Filing Date: May, 17 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: May, 15 2018
    Simplified registration form
    Filing Type: S-3Filing Source: edgar
    Filing Date: May, 15 2018
    Quarterly report with a continuing view of a company's financial position
    Filing Type: 10-QFiling Source: edgar
    Filing Date: May, 15 2018
    Amendment to a previously filed 10-K
    Filing Type: 10-K/AFiling Source: edgar
    Filing Date: April, 30 2018
    Amendment to a previously filed 10-K
    Filing Type: 10-K/AFiling Source: edgar
    Filing Date: April, 30 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: April, 06 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: April, 06 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: March, 28 2018
    Annual report with a comprehensive overview of the company
    Filing Type: 10-KFiling Source: edgar
    Filing Date: March, 28 2018

     

     


    Daily Technical Chart for (NASDAQ: BIOC)

    Daily Technical Chart for (NASDAQ: BIOC)


    Stay tuned for daily updates and more on (NASDAQ: BIOC)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: BIOC)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BIOC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of BIOC and does not buy, sell, or trade any shares of BIOC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/